Richter's transformation to diffuse large B-cell lymphoma: a retrospective study reporting clinical data, outcome, and the benefit of adding rituximab to chemotherapy, from the Israeli CLL Study Group

American journal of hematology

Volumn 89, Issue 11, 2014, Pages E218-E222

  Tadmor, Tamar ^a   Shvidel, Lev ^a   Bairey, Osnat ^a   Goldschmidt, Neta ^a   Ruchlemer, Rosa ^a   Fineman, Riva ^a   Rahimi Levene, Naomi ^a   Herishanu, Yair ^a   Yuklea, Mona ^a   Arad, Ariela ^a   Aviv, Ariel ^a   Polliack, Aaron ^a  

^a BNAI ZION MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY; RITUXIMAB;

ADULT; AGED; CLINICAL TRIAL; DISEASE COURSE; EPIDEMIOLOGY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; ISRAEL; KAPLAN MEIER METHOD; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; LEUKOCYTE COUNT; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; RISK FACTOR; SALVAGE THERAPY; SEVERITY OF ILLNESS INDEX; SYMPTOM ASSESSMENT; SYNDROME; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; ISRAEL; KAPLAN-MEIER ESTIMATE; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; LEUKOCYTE COUNT; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; SALVAGE THERAPY; SEVERITY OF ILLNESS INDEX; SYMPTOM ASSESSMENT; SYNDROME; TREATMENT OUTCOME;

EID: 85027920668     PISSN: None     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23826     Document Type: Article

References (0)